An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
Toggle navigation
JPEO-CBRND
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
JPEO-CBRND
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Search
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Home
About
Leadership
Joint Project Managers & Joint Project Leads
Our Story
Resources
Media
News
Photography
Work With Us
JETT - Joint Enterprise Technology Tool
SPARK
Careers
Contact
News
Results:
Archive:
February, 2021
Biden Administration secures supply of new COVID-19 therapeutic treatment
February 26, 2021
— FOR IMMEDIATE RELEASE - The Biden Administration announced today that it has secured a supply of a recently authorized COVID-19 therapeutic treatment. The U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) collaborated to purchase 100,000 treatment courses of a second therapeutic treatment from Eli Lilly and...
MORE
SARPAC Clinical Trial of Leukine® (sargramostim, rhu GM-CSF) in Hospitalized COVID-19 Patients Meets Primary Endpoint of Significant Improvement in Lung Function
February 26, 2021
— Link to full article - https://www.prnewswire.com/news-releases/sarpac-clinical-trial-of-leukine-sargramostim-rhu-gm-csf-in-hospitalized-covid-19-patients-meets-primary-endpoint-of-significant-improvement-in-lung-function-301236275.html
MORE
Biden Administration purchases additional doses of COVID-19 vaccines from Pfizer and Moderna
February 12, 2021
— FOR IMMEDIATE RELEASE - The U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) have purchased an additional 100 million doses of COVID-19 vaccines from both Pfizer Inc. and Moderna Inc. to help meet demand for COVID-19 vaccines in the United States.The orders placed today bring the vaccine purchased by the U.S...
MORE
DOD Awards Industry Partner Immunome $13.3 Million for Biosynthetic Convalescent Plasma Development
February 11, 2021
— The JPM CBRN Medical leveraged an industry partnership to accelerate COVID-19 prevention and treatment research...
MORE
DOD Awards $231.8 Million Contract to Ellume USA LLC to Increase Domestic Production Capacity and Deliver COVID-19 Home Tests
February 1, 2021
— FOR IMMEDIATE RELEASE - On Feb. 1, 2021, the Department of Defense (DOD), in coordination with the Department of Health and Human Services, awarded $231.8 million to Ellume USA LLC to onshore production capacity of the Ellume COVID-19 Home Test for the United States.This industrial base expansion effort will allow Ellume USA LLC to increase...
MORE
News Search
News Archive - Search by Year and Month
2024 (37)
2023 (36)
2022 (31)
2021 (37)
December (1)
November (6)
October (2)
September (1)
July (1)
June (1)
May (8)
April (6)
March (2)
February (5)
January (4)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)
JPEO-CBRND Press Kit
Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.
JPEO-CBRND Public Affairs Office
The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.